Alamar Biosciences, Inc.

📍 Fremont, United States🗓 Founded 2018👥 207 employees💰 Last funded Apr 2024
Biotechnology Research🌐 alamarbio.com
Website LinkedIn
Alamar Biosciences is powering precision proteomics with automated, high throughput solutions for ultra-high sensitivity protein analysis across a range of multiplex levels. Our proprietary NULISA™ Chemistry utilizes a novel sequential capture and release method that significantly reduces background signal and increases the sensitivity and dynamic range compared with standard approaches and allows both qPCR and NGS readouts. The NULISAseq Inflammation Panel contains 200+ important markers related to immune and inflammatory diseases and will run on our ARGO™ System. This innovative platform allows for a fully automated workflow with less than 30 minutes hands on time from sample to data.
4
Total investors
3
Early stage
0
Mid stage
1
Late stage
2018
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
3
China
1
Investor activity2017–2024 · investors recorded per year
20171201912020120241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Alamar Biosciences, Inc.?
Alamar Biosciences, Inc. has 4 investors on record on gritt.io, including 3 early-stage backers and 1 late-stage investors.
When did Alamar Biosciences, Inc. last raise funding?
The most recent investment in Alamar Biosciences, Inc. recorded on gritt.io was in April 2024.
When was Alamar Biosciences, Inc. founded?
Alamar Biosciences, Inc. was founded in 2018.
What industry is Alamar Biosciences, Inc. in?
Alamar Biosciences, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Alamar Biosciences, Inc. based?
Alamar Biosciences, Inc. is headquartered in Fremont, United States.